Generation of Major Human Excretory and Circulating Drug Metabolites Using a Hepatocyte Relay Method

被引:14
作者
Ballard, T. Eric [1 ]
Orozco, Christine C. [1 ]
Obach, R. Scott [1 ]
机构
[1] Pfizer Inc, Pharmacokinet Dynam & Metab, Groton, CT 06340 USA
关键词
TOXICITY;
D O I
10.1124/dmd.114.057026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The prediction of human drug metabolites using in vitro experiments containing human-derived reagents is an important approach in modern drug research; however, this can be challenging for drugs that are slowly metabolized. In this report, we describe the use of a recently developed human hepatocyte relay method for the purpose of predicting human drug metabolite profiles. Five compounds for which in vivo human metabolism data were available were selected for the investigation of this method, and the results were compared with data gathered in hepatocyte suspensions as well as previous data from a micropatterned hepatocyte coculture method. The hepatocyte relay method demonstrated an improved performance (generation of 75% of human in vivo metabolites) for those drugs for which previous methods showed a relatively low rate of success (50% of human in vivo metabolites). Metabolites included those arising from both oxidative and conjugative reactions and metabolites that required sequential reactions. Two 4-hour relays were shown to adequately generate metabolites, and no further benefit was derived from more relays. Overall, it can be concluded that the hepatocyte relay assay method can be successfully used in the generation of relevant human metabolites, even for challenging drugs.
引用
收藏
页码:899 / 902
页数:4
相关论文
共 12 条
[1]   Predicting Circulating Human Metabolites: How Good Are We? [J].
Anderson, Shelby ;
Luffer-Atlas, Debra ;
Knadler, Mary Pat .
CHEMICAL RESEARCH IN TOXICOLOGY, 2009, 22 (02) :243-256
[2]   Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism [J].
Baillie, Thomas A. .
CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (01) :129-137
[3]   Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating Metabolites [J].
Dalvie, Deepak ;
Obach, R. Scott ;
Kang, Ping ;
Prakash, Chandra ;
Loi, Cho-Ming ;
Hurst, Susan ;
Nedderman, Angus ;
Goulet, Lance ;
Smith, Evan ;
Bu, Hai-Zhi ;
Smith, Dennis A. .
CHEMICAL RESEARCH IN TOXICOLOGY, 2009, 22 (02) :357-368
[4]   In Vitro-In Vivo Correlation for Low-Clearance Compounds Using Hepatocyte Relay Method [J].
Di, Li ;
Atkinson, Karen ;
Orozco, Christine C. ;
Funk, Carrie ;
Zhang, Hui ;
McDonald, Thomas S. ;
Tan, Beijing ;
Lin, Jian ;
Chang, Cheng ;
Obach, R. Scott .
DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) :2018-2023
[5]   A Novel Relay Method for Determining Low-Clearance Values [J].
Di, Li ;
Trapa, Patrick ;
Obach, R. Scott ;
Atkinson, Karen ;
Bi, Yi-An ;
Wolford, Angela C. ;
Tan, Beijing ;
McDonald, Thomas S. ;
Lai, Yurong ;
Tremaine, Larry M. .
DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) :1860-1865
[6]   New hepatocyte in vitro systems for drug metabolism:: Metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures [J].
Gebhardt, R ;
Hengstler, JG ;
Müller, D ;
Glöckner, R ;
Buenning, P ;
Laube, B ;
Schmelzer, E ;
Ullrich, M ;
Utesch, D ;
Hewitt, N ;
Ringel, M ;
Hilz, BR ;
Bader, A ;
Langsch, A ;
Koose, T ;
Burger, HJ ;
Maas, J ;
Oesch, F .
DRUG METABOLISM REVIEWS, 2003, 35 (2-3) :145-213
[7]  
Kerns EH, 2008, DRUG-LIKE PROPERTIES: CONCEPTS, STRUCTURE DESIGN AND METHODS, P329, DOI 10.1016/B978-012369520-8.50030-9
[8]  
Lin JH, 1997, PHARMACOL REV, V49, P403
[9]  
Pelkonen Olavi, 2005, Expert Opin Drug Metab Toxicol, V1, P49, DOI 10.1517/17425255.1.1.49
[10]   Strategies for using in vitro screens in drug metabolism [J].
Plant, N .
DRUG DISCOVERY TODAY, 2004, 9 (07) :328-336